Dr Reddy’s Credits Launches For Growth Across All Markets
As Company’s Europe And India Business Stand Out
Dr Reddy’s has seen double-digit growth in its global generics segment for its full financial year ended in March, with Europe and India performing well on the back of new launches. The company plans to continue building its pipeline.
